Traded Dec 11, 2025 · Filed Dec 13, 2025
Freeport-McMoRan's Chief Accounting Officer sold $456K of Freeport-McMoRan shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$456,202
Shares × reported transaction price
49 days after results of Oct 23, 2025, 42 days before results of Jan 22, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $48.11 on Dec 11, 2025, at its 52-week high, after a 14% rise over the previous 30 trading days
52-week range $29.15 (Apr 4, 2025) to $48.11 (Dec 11, 2025), 100% of the way up, from 250 adjusted closes. 30 trading days earlier: $42.19 on Oct 29, 2025. Describes the past only, not a forecast
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Nov 13, 2025 in the U.S. District Court, D. Arizona. A filing is an allegation, not a finding.
Reed v. Freeport-McMoran Incorporated, docket 2:25-cv-04243, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.6% | +0.6% | +6.0% |
| 30 days | +27.0% | +1.4% | +25.6% |
| 90 days | +21.9% | -1.7% | +23.6% |
| 180 days | +47.6% | +10.9% | +36.7% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Congressional trade2 different filers disclosed FCX within 90 days. Disclosed 27 days after the transaction; reported as an official range, not an exact amount.